1887

Abstract

Outbreaks of hepatitis C virus (HCV) infection are associated with unsafe injection practices, intravenous drug abuse and other exposure to blood and body fluids. We report here three outbreaks of HCV infection from Jammu and Kashmir (J&K) State, India, which occurred over a period of 3 years and in which molecular epidemiological investigations identified a presumptive common source of infection, most likely a single healthcare venue. Representative blood samples collected from cases of hepatitis C were sent to the National Centre for Disease Control (NCDC) for molecular characterization. These samples were positive by HCV ELISA. Subsequently, specimens were also tested for the presence of HCV RNA by RT-PCR. Sequencing was carried out for all positive samples. A total of 812 cases were laboratory confirmed by HCV ELISA; a total of 115 samples were sent to the NCDC for RT-PCR, and 77 were positive. Subtype 3a of HCV was found in all samples from Anantnag (February 2013); and for subtype 3b, in all samples from Srinagar (May 2015). Subtypes 3a and 3g were identified from two samples from the Kulgam outbreak (July 2014). A detailed epidemiological investigation should be conducted whenever a cluster of HCV cases is revealed, as this potentially allows for the identification of larger outbreaks. Epidemiological investigations of outbreaks should be further supported by inclusion of molecular tests. Efforts to limit therapeutic injections to only those cases having strong medical/surgical indications and to restrict the use of non-sterile needles are essential to prevent transmission of HCV.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000284
2016-08-01
2020-01-21
Loading full text...

Full text loading...

/deliver/fulltext/jmm/65/8/804.html?itemId=/content/journal/jmm/10.1099/jmm.0.000284&mimeType=html&fmt=ahah

References

  1. Al Olaby R. R., Azzazy H. M.. 2011; Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications. Expert Rev Mol Diagn11:53–64 [CrossRef][PubMed]
    [Google Scholar]
  2. Alexopoulou A., Dourakis S. P.. 2005; Genetic heterogeneity of hepatitis viruses and its clinical significance. Curr Drug Targets Inflamm Allergy4:47–55 [CrossRef][PubMed]
    [Google Scholar]
  3. Ashfaq U. A., Javed T., Rehman S., Nawaz Z., Riazuddin S.. 2011; An overview of HCV molecular biology, replication and immune responses. Virol J8:161 [CrossRef]
    [Google Scholar]
  4. Blackard J. T., Shata M. T., Shire N. J., Sherman K. E.. 2008; Acute hepatitis C virus infection: a chronic problem. Hepatology47:321–331 [CrossRef][PubMed]
    [Google Scholar]
  5. Bréchot C.. 1996; Hepatitis C virus: molecular biology and genetic variability. Dig Dis Sci41:6S–21S[PubMed][CrossRef]
    [Google Scholar]
  6. Chakravarti A., Dogra G., Verma V., Srivastava A. P.. 2011; Distribution pattern of HCV genotypes & its association with viral load. Indian J Med Res133:326–331[PubMed]
    [Google Scholar]
  7. Chakravarti A., Ashraf A., Malik S.. 2013; A study of changing trends of prevalence and genotypic distribution of hepatitis C virus among high risk groups in North India. Indian J Med Microbiol31:354–359 [CrossRef][PubMed]
    [Google Scholar]
  8. Chen S. L., Morgan T. R.. 2006; The natural history of hepatitis C virus (HCV) infection. Int J Med Sc3:47–52 [CrossRef]
    [Google Scholar]
  9. Chevaliez S., Pawlotsky J. M.. 2005; Use of virologic assays in the diagnosis and management of hepatitis C virus infection. Clin Liver Dis9:371–382 [CrossRef][PubMed]
    [Google Scholar]
  10. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M.. 1989; Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science244:359–362 [CrossRef][PubMed]
    [Google Scholar]
  11. Comstock R. D., Mallonee S., Fox J. L., Moolenaar R. L., Vogt T. M., Perz J. F., Bell B. P., Crutcher J. M.. 2004; A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments. Infect Control Hosp Epidemiol25:576–583 [CrossRef][PubMed]
    [Google Scholar]
  12. Davis G. L., Alter M. J., El-Serag H., Poynard T., Jennings L. W.. 2010; Aging of hepatitis C virus (HCV) infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterol138:513–521 [CrossRef]
    [Google Scholar]
  13. Friebe P., Lohmann V., Krieger N., Bartenschlager R.. 2001; Sequences in the 5' nontranslated region of hepatitis C virus required for RNA replication. J Virol75:12047–12057 [CrossRef][PubMed]
    [Google Scholar]
  14. Fukushi S., Katayama K., Kurihara C., Ishiyama N., Hoshino F. B., Ando T., Oya A.. 1994; Complete 5' noncoding region is necessary for the efficient internal initiation of hepatitis C virus RNA. Biochem Biophys Res Commun199:425–432 [CrossRef][PubMed]
    [Google Scholar]
  15. Ghany M. G., Strader D. B., Thomas D. L., Seeff L. B.. American Association for the Study of Liver Diseases 2009; Diagnosis, management, and treatment of hepatitis C: an update. Hepatology49:1335–1374 [CrossRef][PubMed]
    [Google Scholar]
  16. Hall T. A.. 1999; BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser41:95–98
    [Google Scholar]
  17. Honda M., Ping L. H., Rijnbrand R. C., Amphlett E., Clarke B., Rowlands D., Lemon S. M.. 1996; Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology222:31–42 [CrossRef][PubMed]
    [Google Scholar]
  18. Hoofnagle J. H.. 2002; Course and outcome of hepatitis C. Hepatology36:S21–S29[CrossRef]
    [Google Scholar]
  19. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K.. 1990; Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A87:9524–9528 [CrossRef][PubMed]
    [Google Scholar]
  20. Kumar T., Shrivastava A., Kumar A., Laserson K. F., Narain J. P., Venkatesh S., Chauhan L. S., Averhoff F.. 2015; Viral hepatitis surveillance—India, 20112013. MMWR Morb Mortal Wkly Rep64:758–762 [CrossRef][PubMed]
    [Google Scholar]
  21. Leone N., Rizzetto M.. 2005; Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol Dietol51:31–46[PubMed]
    [Google Scholar]
  22. Li Y. P., Ramirez S., Gottwein J. M., Bukh J.. 2011; Non-genotype-specific role of the hepatitis C virus 5' untranslated region in virus production and in inhibition by interferon. Virology421:222–234 [CrossRef][PubMed]
    [Google Scholar]
  23. Lu L., Li C., Yuan J., Lu T., Okamoto H., Murphy D. G.. 2013; Full-length genome sequences of five hepatitis C virus isolates representing subtypes 3g, 3h, 3i and 3k, and a unique genotype 3 variant. J Gen Virol94:543–548 [CrossRef][PubMed]
    [Google Scholar]
  24. Luby S. P., Qamruddin K., Shah A. A., Omair A., Pahsa O., Khan A. J., McCormick J. B., Hoodbhouy F., Fisher-Hoch S.. 1997; The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect119:349–356 [CrossRef][PubMed]
    [Google Scholar]
  25. Ma W., Feng B., Tao Q.. 2001; Murine antibody against E2 can capture hepatitis C virus in vitro. Chin Med J114:860–863[PubMed]
    [Google Scholar]
  26. Masante C., Mahias K., Lourenço S., Dumas E., Cahour A., Trimoulet P., Fleury H., Astier-Gin T., Ventura M.. 2008; Seven nucleotide changes characteristic of the hepatitis C virus genotype 3 5' untranslated region: correlation with reduced in vitro replication. J Gen Virol89:212–221 [CrossRef][PubMed]
    [Google Scholar]
  27. Missiha S. B., Ostrowski M., Heathcote E. J.. 2008; Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors. Gastroenterology134:1699–1714 [CrossRef]
    [Google Scholar]
  28. Mohanraj U., Chavan Y. G., Pawar S. R., Raut A. D.. 2015; Identification of hepatitis C virus genotypes and subtypes in patients from Maharashtra based on 5’UTR sequencing and analysis: a retrospective study. Int J Bioassays4:4601–4607
    [Google Scholar]
  29. Nasu A., Marusawa H., Ueda Y., Nishijima N., Takahashi K., Osaki Y., Yamashita Y., Inokuma T., Tamada T. et al. 2011; Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing. PLoS One6:e24907 [CrossRef][PubMed]
    [Google Scholar]
  30. Negro F.. 2014; Epidemiology of hepatitis C in Europe. Dig Liver Dis46:S158–S164 [CrossRef][PubMed]
    [Google Scholar]
  31. Ohno T., Lau J. Y.. 1996; The “gold-standard,” accuracy, and the current concepts: hepatitis C virus genotype and viremia. Hepatology24:1312–1315 [CrossRef][PubMed]
    [Google Scholar]
  32. Panigrahi A. K., Roca J., Acharya S. K., Jameel S., Panda S. K.. 1996; Genotype determination of hepatitis C virus from northern India: identification of a new subtype. J Med Virol48:191–198 [CrossRef][PubMed]
    [Google Scholar]
  33. Patel D. A., Gupta P. A., Kinariwala D. M., Shah H. S., Trivedi G. R., Vegad M. M.. 2012; An investigation of an outbreak of viral hepatitis B in Modasa town, Gujarat, India. J Glob Infect Dis4:55–59 [CrossRef][PubMed]
    [Google Scholar]
  34. Pawlotsky J. M.. 2003; Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin Liver Dis7:45–66 [CrossRef][PubMed]
    [Google Scholar]
  35. Pestova T. V., Shatsky I. N., Fletcher S. P., Jackson R. J., Hellen C. U.. 1998; A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev12:67–83 [CrossRef][PubMed]
    [Google Scholar]
  36. Razavi H., Waked I., Sarrazin C., Myers R. P., Idilman R., Calinas F., Vogel W., Mendes Correa M. C., Hézode C. et al. 2014; The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat21:34–59 [CrossRef]
    [Google Scholar]
  37. Richter S. S.. 2002; Laboratory assays for diagnosis and management of hepatitis C virus infection. J Clin Microbiol40:4407–4412 [CrossRef][PubMed]
    [Google Scholar]
  38. Savey A., Simon F., Izopet J., Lepoutre A., Fabry J., Desenclos J. C.. 2005; A large nosocomial outbreak of hepatitis C virus infections at a hemodialysis center. Infect Control Hosp Epidemiol26:752–760 [CrossRef][PubMed]
    [Google Scholar]
  39. Sharma S. D.. 2010; Hepatitis C virus: molecular biology & current therapeutic options. Indian J Med Res131:17–34[PubMed]
    [Google Scholar]
  40. Singh S., Malhotra V., Sarin S. K.. 2004; Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in India. Indian J Med Res119:145–148[PubMed]
    [Google Scholar]
  41. Steinhauer D. A., Domingo E., Holland J. J.. 1992; Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene122:281–288 [CrossRef][PubMed]
    [Google Scholar]
  42. Suzuki T., Aizaki H., Murakami K., Shoji I., Wakita T.. 2007; Molecular biology of hepatitis C virus. J Gastroenterol42:411–423 [CrossRef][PubMed]
    [Google Scholar]
  43. Tamura K., Stecher G., Peterson D., Filipski A., Kumar S.. 2013; MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol30:2725–2729 [CrossRef][PubMed]
    [Google Scholar]
  44. Thompson N. D., Perz J. F., Moorman A. C., Holmberg S. D.. 2009; Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998–2008. Ann Intern Med150:33–39 [CrossRef][PubMed]
    [Google Scholar]
  45. Van der Poel C. L., Cuypers H. T., Reesink H. W., Weiner A. J., Quan S., Di Nello R., Van Boven J. J., Winkel I., Mulder-Folkerts D., Exel-Oehlers P. J.. 1991; Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet337:317–319 [CrossRef][PubMed]
    [Google Scholar]
  46. Verma R., Behera B. K., Jain R. B., Arora V., Chayal V., Gill P. S.. 2014; Hepatitis C, a silent threat to the community of Haryana, India: a community-based study. Australas Med J7:11–16 [CrossRef][PubMed]
    [Google Scholar]
  47. World Health Organization 2002; Hepatitis C. (accessed 23rd October 2015)http://www.who.int/csr/disease/hepatitis/Hepc.pdf?ua=1
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000284
Loading
/content/journal/jmm/10.1099/jmm.0.000284
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error